Literature DB >> 2227481

Intraocular pressure in patients with Cushing's disease.

J B Jonas1, O Huschle, G Koniszewski, M Buchfelder, R Fahlbusch.   

Abstract

Externally applied corticosteroids increase the intraocular pressure in one-third of the general population. We evaluated the intraocular pressure in 62 patients with endogenously elevated serum cortisol levels due to hypothalamic pituitary-dependent Cushing's disease. All patients underwent transphenoidal microsurgical sella exploration within 4 years after the onset of subjective symptoms. The intraocular pressure (preoperative mean, 14.9 +/- 3.5 mm Hg) exceeded 21 mm Hg in four eyes before surgery and in one eye after surgery (postoperative mean, 14.3 +/- 2.8 mm Hg). In patients attaining postoperative remission and whose pressure readings were taken at least 3 months after surgery, the postoperative intraocular pressure was significantly (P = 0.04) lower than that measured preoperatively (14.2 +/- 2.7 vs 13.0 +/- 2.0 mm Hg). Biomorphometry of the optic disc topography and the retinal nerve-fiber layer in 19 patients revealed no glaucomatous changes. In contrast to topically applied corticosteroids, endogenously elevated serum cortisol levels in patients with hypothalamic pituitary-dependent Cushing's disease increased intraocular pressure only slightly, with no great risk of glaucomatous optic nerve damage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227481     DOI: 10.1007/bf00927251

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  17 in total

1.  EFFECT OF CORTICOSTEROIDS ON INTRAOCULAR PRESSURE AND FLUID DYNAMICS. I. THE EFFECT OF DEXAMETHASONE IN THE NORMAL EYE.

Authors:  M F ARMALY
Journal:  Arch Ophthalmol       Date:  1963-10

2.  CORTICOSTEROIDS AND INTRAOCULAR PRESSURE.

Authors:  B BECKER; D W MILLS
Journal:  Arch Ophthalmol       Date:  1963-10

3.  Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma.

Authors:  J M Lewis; T Priddy; J Judd; M O Gordon; M A Kass; A E Kolker; B Becker
Journal:  Am J Ophthalmol       Date:  1988-11-15       Impact factor: 5.258

4.  A 16-year follow-up in a corticosteroid-sensitive patient with glaucoma secondary to a benign adrenal adenoma.

Authors:  D S Robbin; J S Haas
Journal:  Am J Ophthalmol       Date:  1989-03-15       Impact factor: 5.258

5.  Plasma cortisol differences between normal and glaucomatous patients: before and after dexamethasone suppresion.

Authors:  B Schwartz; R Z Levene
Journal:  Arch Ophthalmol       Date:  1972-04

6.  [Ocular changes in Cushing's syndrome].

Authors:  H P Neuner; U Dardenne
Journal:  Klin Monbl Augenheilkd       Date:  1968       Impact factor: 0.700

7.  Pseudoglaucomatous physiologic large cups.

Authors:  J B Jonas; F M Zäch; G C Gusek; G O Naumann
Journal:  Am J Ophthalmol       Date:  1989-02-15       Impact factor: 5.258

8.  Ocular complications of systemic steroid after renal transplantation and their association with HLA.

Authors:  H P Adhikary; R A Sells; P K Basu
Journal:  Br J Ophthalmol       Date:  1982-05       Impact factor: 4.638

9.  The heritable nature of dexamethasone-induced ocular hypertension.

Authors:  M F Armaly
Journal:  Arch Ophthalmol       Date:  1966-01

10.  Increased intraocular pressure induced by corticosteroids.

Authors:  Y Kitazawa
Journal:  Am J Ophthalmol       Date:  1976-09       Impact factor: 5.258

View more
  3 in total

1.  A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA Sequencing.

Authors:  Jaclyn Y Bermudez; Hannah C Webber; Bartley Brown; Terry A Braun; Abbot F Clark; Weiming Mao
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

2.  CUSHING DISEASE MASQUERADING AS GLAUCOMA.

Authors:  Yumiko Tsushima; Lubna Bashir Munshi; Charit Taneja; Se-Min Kim
Journal:  AACE Clin Case Rep       Date:  2019-06-07

3.  Intraocular pressure and its correlation with midnight plasma cortisol level in Cushing's disease and other endogenous Cushing's syndrome.

Authors:  Priyadarshini Mishra; Alok Pratap Singh; Vikas Kanaujia; Rachna Agarwal; Prabhaker Mishra; Ashwani Guleria; Alka Tripathi
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.